Responses
Regular and Young Investigator Award Abstracts
Immuno-Engineering
1220 Development of B cell maturation antigen (BCMA)-specific CD8+ cytotoxic T lymphocytes using induced pluripotent stem cell technology for multiple myeloma
Compose a Response to This Article
Other responses
No responses have been published for this article.